Plancorp, LLC Denali Therapeutics Inc. Transaction History

Plancorp, LLC

  • $2.44 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$48.48 - $78.23 $140,592 - $226,867
-2,900 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$50.3 - $78.44 $145,870 - $227,476
2,900 New
2,900 $227,000
Q1 2021

May 14, 2021
SELL
$53.8 - $81.53 $179,315 - $271,739
-3,333 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$36.89 - $93.56 $122,954 - $311,835
3,333 New
3,333 $279,000

Others Institutions Holding DNLI

# of Institutions
227
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.94B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Plancorp, LLC Portfolio

Follow Plancorp, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plancorp, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plancorp, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email